<DOC>
	<DOCNO>NCT00754949</DOCNO>
	<brief_summary>The purpose study determine AzaSite Plus effective safe treatment blepharoconjunctivitis compare AzaSite alone Dexamethasone alone .</brief_summary>
	<brief_title>Comparative Study AzaSite Plus Compared AzaSite Alone Dexamethasone Alone Treat Subjects With Blepharoconjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Have clinical diagnosis blepharoconjunctivitis Must willing discontinue contact lens wear duration study Have best correct visual acuity 6/24 eye Have IOP less equal 25 mmHg either eye Have know sensitivity poor tolerance component study medication Have history eyelid and/or ocular surgery and/or ocular surgical intervention within 6 month prior visit 1 study and/or history refractive surgery within 6 month Have wear contact lenses 72 hour prior visit 1 and/or need wear contact lenses duration study Have use topical ophthalmic solution include tear substitute within 2 hour enrollment Use eye makeup study Have uncontrolled systemic disease debilitate disease Have diagnose glaucoma Have clinically significant cardiovascular disorder Have history liver kidney disease result persist dysfunction Have prior ( within 30 day begin study treatment ) anticipate concurrent use investigational drug device</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Blepharoconjunctivitis ,</keyword>
	<keyword>Ophthalmology</keyword>
</DOC>